---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-088629"
form_type: "8-K"
ticker: "NOTV"
cik: "0000720154"
company_name: "Inotiv, Inc."
filed_at: "2022-08-10T23:59:59+00:00"
generated_at: "2026-06-24T01:39:15.178594+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Inotiv Q3 FY2022 revenue rises to $172.7M; raises FY2022 revenue guidance to at least $550M

## Summary
- Q3 FY2022 revenue $172.7M vs $22.9M a year ago; DSA revenue $49.2M (+114.8% YoY), RMS $123.4M from nil.
- Net loss $(3.6)M vs net income $2.6M in Q3 FY2021; adjusted EBITDA $37.0M (21.4% rev) vs $2.2M (9.6%).
- Raises FY2022 revenue guidance to at least $550M (from $510M); adjusted EBITDA margin at least 17.0% (from 15.0%).
- DSA backlog $143.2M at June 30, 2022, up from $62.0M a year ago; book-to-bill 1.19x.
- YTD cash used in ops $5.4M; debt $338.8M; subsequent acquisition of Protypia for large molecule bioanalysis.

## SEC filing metadata
- accession: 0001104659-22-088629
- form_type: 8-K
- ticker: NOTV
- cik: 0000720154
- company_name: Inotiv, Inc.
- filed_at: 2022-08-10T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/720154/000110465922088629/0001104659-22-088629-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/720154/000110465922088629/tm2223117d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-088629
- JSON: https://secwatch.observer/filing/0001104659-22-088629.json
- Plain text: https://secwatch.observer/filing/0001104659-22-088629.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.